cis-(2S,3R)-N-[(6S,7S,13S)-20-[5-[(3R)-3-(4-cyclopropylpiperazin-1-yl)but-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,29-tetrazahexacyclo[17.5.2.12,5.19,13.110,12.022,26]nonacosa-1(25),2,5(29),19,22(26),23-hexaen-7-yl]-2,3-dimethylcyclopropane-1-carboxamide

C61H81N9O8S — CID 178173319

IUPACcis-(2S,3R)-N-[(6S,7S,13S)-20-[5-[(3R)-3-(4-cyclopropylpiperazin-1-yl)but-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,29-tetrazahexacyclo[17.5.2.12,5.19,13.110,12.022,26]nonacosa-1(25),2,5(29),19,22(26),23-hexaen-7-yl]-2,3-dimethylcyclopropane-1-carboxamide
SMILESCO[C@H](C)c1ncc(C#C[C@@H](C)N2CCN(C3CC3)CC2)cc1-c1c2c3cc(ccc3n1CCOC1CCOCC1)-c1csc(n1)[C@@H](N1CCOCC1)[C@@H](NC(=O)C1[C@@H](C)[C@H]1C)C(=O)N1N[C@H](C(=O)OCC(C)(C)C2)C2CC1C2
InChIInChI=1S/C61H81N9O8S/c1-36(66-16-18-67(19-17-66)43-11-12-43)8-9-40-28-47(52(62-33-40)39(4)74-7)55-48-32-61(5,6)35-78-60(73)53-42-29-44(30-42)70(65-53)59(72)54(64-57(71)51-37(2)38(51)3)56(68-20-25-76-26-21-68)58-63-49(34-79-58)41-10-13-50(46(48)31-41)69(55)22-27-77-45-14-23-75-24-15-45/h10,13,28,31,33-34,36-39,42-45,51,53-54,56,65H,11-12,14-27,29-30,32,35H2,1-7H3,(H,64,71)/t36-,37-,38+,39-,42?,44?,51?,53+,54-,56+/m1/s1
InChIKeyBOEPDAQTEGHBJM-NPCJQDJTSA-N
MW1100.44 g/mol
LogP6.63
Rot. Bonds12

About cis-(2S,3R)-N-[(6S,7S,13S)-20-[5-[(3R)-3-(4-cyclopropylpiperazin-1-yl)but-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,29-tetrazahexacyclo[17.5.2.12,5.19,13.110,12.022,26]nonacosa-1(25),2,5(29),19,22(26),23-hexaen-7-yl]-2,3-dimethylcyclopropane-1-carboxamide

cis-(2S,3R)-N-[(6S,7S,13S)-20-[5-[(3R)-3-(4-cyclopropylpiperazin-1-yl)but-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,29-tetrazahexacyclo[17.5.2.12,5.19,13.110,12.022,26]nonacosa-1(25),2,5(29),19,22(26),23-hexaen-7-yl]-2,3-dimethylcyclopropane-1-carboxamide (PubChem CID 178173319) has the molecular formula C61H81N9O8S and a molecular weight of 1100.44 g/mol. Its IUPAC name is cis-(2S,3R)-N-[(6S,7S,13S)-20-[5-[(3R)-3-(4-cyclopropylpiperazin-1-yl)but-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,29-tetrazahexacyclo[17.5.2.12,5.19,13.110,12.022,26]nonacosa-1(25),2,5(29),19,22(26),23-hexaen-7-yl]-2,3-dimethylcyclopropane-1-carboxamide.

Molecular Properties

Compound Namecis-(2S,3R)-N-[(6S,7S,13S)-20-[5-[(3R)-3-(4-cyclopropylpiperazin-1-yl)but-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,29-tetrazahexacyclo[17.5.2.12,5.19,13.110,12.022,26]nonacosa-1(25),2,5(29),19,22(26),23-hexaen-7-yl]-2,3-dimethylcyclopropane-1-carboxamide
PubChem CID178173319
Molecular FormulaC61H81N9O8S
Molecular Weight1100.44 g/mol
Exact Mass1099.59
IUPAC Namecis-(2S,3R)-N-[(6S,7S,13S)-20-[5-[(3R)-3-(4-cyclopropylpiperazin-1-yl)but-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,29-tetrazahexacyclo[17.5.2.12,5.19,13.110,12.022,26]nonacosa-1(25),2,5(29),19,22(26),23-hexaen-7-yl]-2,3-dimethylcyclopropane-1-carboxamide
SMILESCO[C@H](C)c1ncc(C#C[C@@H](C)N2CCN(C3CC3)CC2)cc1-c1c2c3cc(ccc3n1CCOC1CCOCC1)-c1csc(n1)[C@@H](N1CCOCC1)[C@@H](NC(=O)C1[C@@H](C)[C@H]1C)C(=O)N1N[C@H](C(=O)OCC(C)(C)C2)C2CC1C2
InChIInChI=1S/C61H81N9O8S/c1-36(66-16-18-67(19-17-66)43-11-12-43)8-9-40-28-47(52(62-33-40)39(4)74-7)55-48-32-61(5,6)35-78-60(73)53-42-29-44(30-42)70(65-53)59(72)54(64-57(71)51-37(2)38(51)3)56(68-20-25-76-26-21-68)58-63-49(34-79-58)41-10-13-50(46(48)31-41)69(55)22-27-77-45-14-23-75-24-15-45/h10,13,28,31,33-34,36-39,42-45,51,53-54,56,65H,11-12,14-27,29-30,32,35H2,1-7H3,(H,64,71)/t36-,37-,38+,39-,42?,44?,51?,53+,54-,56+/m1/s1
InChIKeyBOEPDAQTEGHBJM-NPCJQDJTSA-N
XLogP6.63
TPSA165.09 Ų
H-Bond Donors2
H-Bond Acceptors16
Rotatable Bonds12
Heavy Atoms79
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001100.44
LogP ≤ 56.63
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze cis-(2S,3R)-N-[(6S,7S,13S)-20-[5-[(3R)-3-(4-cyclopropylpiperazin-1-yl)but-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,29-tetrazahexacyclo[17.5.2.12,5.19,13.110,12.022,26]nonacosa-1(25),2,5(29),19,22(26),23-hexaen-7-yl]-2,3-dimethylcyclopropane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of cis-(2S,3R)-N-[(6S,7S,13S)-20-[5-[(3R)-3-(4-cyclopropylpiperazin-1-yl)but-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,29-tetrazahexacyclo[17.5.2.12,5.19,13.110,12.022,26]nonacosa-1(25),2,5(29),19,22(26),23-hexaen-7-yl]-2,3-dimethylcyclopropane-1-carboxamide?
The IUPAC name of cis-(2S,3R)-N-[(6S,7S,13S)-20-[5-[(3R)-3-(4-cyclopropylpiperazin-1-yl)but-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,29-tetrazahexacyclo[17.5.2.12,5.19,13.110,12.022,26]nonacosa-1(25),2,5(29),19,22(26),23-hexaen-7-yl]-2,3-dimethylcyclopropane-1-carboxamide (CID 178173319) is cis-(2S,3R)-N-[(6S,7S,13S)-20-[5-[(3R)-3-(4-cyclopropylpiperazin-1-yl)but-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,29-tetrazahexacyclo[17.5.2.12,5.19,13.110,12.022,26]nonacosa-1(25),2,5(29),19,22(26),23-hexaen-7-yl]-2,3-dimethylcyclopropane-1-carboxamide.
What is the SMILES notation for cis-(2S,3R)-N-[(6S,7S,13S)-20-[5-[(3R)-3-(4-cyclopropylpiperazin-1-yl)but-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,29-tetrazahexacyclo[17.5.2.12,5.19,13.110,12.022,26]nonacosa-1(25),2,5(29),19,22(26),23-hexaen-7-yl]-2,3-dimethylcyclopropane-1-carboxamide?
The canonical SMILES for cis-(2S,3R)-N-[(6S,7S,13S)-20-[5-[(3R)-3-(4-cyclopropylpiperazin-1-yl)but-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,29-tetrazahexacyclo[17.5.2.12,5.19,13.110,12.022,26]nonacosa-1(25),2,5(29),19,22(26),23-hexaen-7-yl]-2,3-dimethylcyclopropane-1-carboxamide is CO[C@H](C)c1ncc(C#C[C@@H](C)N2CCN(C3CC3)CC2)cc1-c1c2c3cc(ccc3n1CCOC1CCOCC1)-c1csc(n1)[C@@H](N1CCOCC1)[C@@H](NC(=O)C1[C@@H](C)[C@H]1C)C(=O)N1N[C@H](C(=O)OCC(C)(C)C2)C2CC1C2.
What is the InChIKey of cis-(2S,3R)-N-[(6S,7S,13S)-20-[5-[(3R)-3-(4-cyclopropylpiperazin-1-yl)but-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,29-tetrazahexacyclo[17.5.2.12,5.19,13.110,12.022,26]nonacosa-1(25),2,5(29),19,22(26),23-hexaen-7-yl]-2,3-dimethylcyclopropane-1-carboxamide?
The InChIKey is BOEPDAQTEGHBJM-NPCJQDJTSA-N. The full InChI is InChI=1S/C61H81N9O8S/c1-36(66-16-18-67(19-17-66)43-11-12-43)8-9-40-28-47(52(62-33-40)39(4)74-7)55-48-32-61(5,6)35-78-60(73)53-42-29-44(30-42)70(65-53)59(72)54(64-57(71)51-37(2)38(51)3)56(68-20-25-76-26-21-68)58-63-49(34-79-58)41-10-13-50(46(48)31-41)69(55)22-27-77-45-14-23-75-24-15-45/h10,13,28,31,33-34,36-39,42-45,51,53-54,56,65H,11-12,14-27,29-30,32,35H2,1-7H3,(H,64,71)/t36-,37-,38+,39-,42?,44?,51?,53+,54-,56+/m1/s1.
What are the key properties of cis-(2S,3R)-N-[(6S,7S,13S)-20-[5-[(3R)-3-(4-cyclopropylpiperazin-1-yl)but-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,29-tetrazahexacyclo[17.5.2.12,5.19,13.110,12.022,26]nonacosa-1(25),2,5(29),19,22(26),23-hexaen-7-yl]-2,3-dimethylcyclopropane-1-carboxamide?
cis-(2S,3R)-N-[(6S,7S,13S)-20-[5-[(3R)-3-(4-cyclopropylpiperazin-1-yl)but-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,29-tetrazahexacyclo[17.5.2.12,5.19,13.110,12.022,26]nonacosa-1(25),2,5(29),19,22(26),23-hexaen-7-yl]-2,3-dimethylcyclopropane-1-carboxamide has a molecular weight of 1100.44 g/mol, XLogP of 6.63, 12 rotatable bonds, 2 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for cis-(2S,3R)-N-[(6S,7S,13S)-20-[5-[(3R)-3-(4-cyclopropylpiperazin-1-yl)but-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,29-tetrazahexacyclo[17.5.2.12,5.19,13.110,12.022,26]nonacosa-1(25),2,5(29),19,22(26),23-hexaen-7-yl]-2,3-dimethylcyclopropane-1-carboxamide is sourced from PubChem (CID 178173319), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).